These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12183243)

  • 1. In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.
    Wiesner J; Henschker D; Hutchinson DB; Beck E; Jomaa H
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2889-94. PubMed ID: 12183243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosmidomycin for the treatment of malaria.
    Wiesner J; Borrmann S; Jomaa H
    Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
    Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
    Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs of reverse fosmidomycin analogues.
    Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
    J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin.
    Guggisberg AM; Sundararaman SA; Lanaspa M; Moraleda C; González R; Mayor A; Cisteró P; Hutchinson D; Kremsner PG; Hahn BH; Bassat Q; Odom AR
    J Infect Dis; 2016 Oct; 214(7):1085-91. PubMed ID: 27443612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
    Zhang B; Watts KM; Hodge D; Kemp LM; Hunstad DA; Hicks LM; Odom AR
    Biochemistry; 2011 May; 50(17):3570-7. PubMed ID: 21438569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.
    Fernandes JF; Lell B; Agnandji ST; Obiang RM; Bassat Q; Kremsner PG; Mordmüller B; Grobusch MP
    Future Microbiol; 2015; 10(8):1375-90. PubMed ID: 26228767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activity.
    Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2163-6. PubMed ID: 12798327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria.
    Na-Bangchang K; Ruengweerayut R; Karbwang J; Chauemung A; Hutchinson D
    Malar J; 2007 May; 6():70. PubMed ID: 17531088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
    Borrmann S; Issifou S; Esser G; Adegnika AA; Ramharter M; Matsiegui PB; Oyakhirome S; Mawili-Mboumba DP; Missinou MA; Kun JF; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Nov; 190(9):1534-40. PubMed ID: 15478056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.
    Borrmann S; Lundgren I; Oyakhirome S; Impouma B; Matsiegui PB; Adegnika AA; Issifou S; Kun JF; Hutchinson D; Wiesner J; Jomaa H; Kremsner PG
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2713-8. PubMed ID: 16870763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.
    Ruangweerayut R; Looareesuwan S; Hutchinson D; Chauemung A; Banmairuroi V; Na-Bangchang K
    Malar J; 2008 Oct; 7():225. PubMed ID: 18973702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
    Courtens C; Risseeuw M; Caljon G; Maes L; Martin A; Van Calenbergh S
    Bioorg Med Chem; 2019 Mar; 27(5):729-747. PubMed ID: 30692024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosmidomycin, a novel chemotherapeutic agent for malaria.
    Lell B; Ruangweerayut R; Wiesner J; Missinou MA; Schindler A; Baranek T; Hintz M; Hutchinson D; Jomaa H; Kremsner PG
    Antimicrob Agents Chemother; 2003 Feb; 47(2):735-8. PubMed ID: 12543685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprenoid biosynthesis of the apicoplast as drug target.
    Wiesner J; Jomaa H
    Curr Drug Targets; 2007 Jan; 8(1):3-13. PubMed ID: 17266527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues.
    Faísca Phillips AM; Nogueira F; Murtinheira F; Barros MT
    Bioorg Med Chem Lett; 2015; 25(10):2112-6. PubMed ID: 25881827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors.
    Haemers T; Wiesner J; Van Poecke S; Goeman J; Henschker D; Beck E; Jomaa H; Van Calenbergh S
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1888-91. PubMed ID: 16439126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC.
    Konzuch S; Umeda T; Held J; Hähn S; Brücher K; Lienau C; Behrendt CT; Gräwert T; Bacher A; Illarionov B; Fischer M; Mordmüller B; Tanaka N; Kurz T
    J Med Chem; 2014 Nov; 57(21):8827-38. PubMed ID: 25254502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum.
    Cassera MB; Gozzo FC; D'Alexandri FL; Merino EF; del Portillo HA; Peres VJ; Almeida IC; Eberlin MN; Wunderlich G; Wiesner J; Jomaa H; Kimura EA; Katzin AM
    J Biol Chem; 2004 Dec; 279(50):51749-59. PubMed ID: 15452112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
    Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.